PAM
Pan Asia Metals Limited
🇦🇺 ASX
⛏️ MINING
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
-16.96%
Annual Growth
4 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
7
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Pan Asia Metals Ltd. engages in the identification, exploration, development, and operation of metal properties. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2020-10-08. The principal activities of its subsidiaries are in the identification and development of specialty metals assets situated in low-cost environments which are proximal to advanced industrial centers. The company has lithium projects in South-East Asia and South America, and agreements with key battery and chemical producers in the Asian region to produce advanced battery chemicals. The Reung Kiet Lithium Project is a lepidolite-style lithium project located about 70 kilometers (km) northeast of Phuket in the Phang Nga Province in southern Thailand. The Tama Atacama Lithium Project is a series of brine and clay lithium holdings located in the Atacama Desert in Northern Chile. The Kata Thong Geothermal Lithium & Hard Rock Lithium-Tin Project is a compilation of five Special Prospecting License Applications in the Phang Nga Province in southern Thailand covering approximately 45 square kilometers.
📈 Performance
Price History
-70.00%
1M
1Y
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.06
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in PAM
7
📊 Total Capital Earnings
$10K
🔃 Average investment frequency
35 weeks
💵 Average investment amount
$2,080
⏰ Last time a customer invested in PAM
82 days
PAM investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
13%
50k - 100k
75%
Less than 50k
13%
👶 Age of investors
18 - 25
26 - 34
71%
35 - 90
29%
🙋 Legal gender of investors
Female
57%
Male
43%
Pearlers who invest in PAM also invest in...
Sayona Mining Ltd. engages in sourcing and developing raw materials required for constructing lithium-ion batteries. The company is headquartered in Brisbane, Queensland. The company went IPO on 2004-03-30. The firm's projects include Authier Lithium Project, Tansim Lithium Project, Moblan Lithium Project, Lac Albert Lithium Project, Western Australia Lithium Projects, Western Australia Gold Projects, and Western Australia Graphite Projects. The Authier Lithium project is situated approximately 45 kilometers (km) northwest of the city of Val d'Or, a mining service center in Quebec. The project area comprises 19 mineral claims totaling 653 hectares and extends approximately 3.4 km in the east-west, and 3.1 km in a north-south direction, respectively. The Tansim Lithium project is situated approximately 82 km southwest of the Authier Lithium Project. The project comprises 355 mineral claims spanning 20,546 hectares (ha) and is prospective for lithium, tantalum, and beryllium. The Moblan Lithium project is located in the Eeyou-Istchee James Bay region of northern Quebec.
🙌 Performance (5Yr p.a)
41.93%
📊 Share price
$0.03 AUD
📈 HIGH PRICE GROWTH
⛏️ MINING
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
4.35%
📊 Share price
$104.33 AUD
⛳️ DIVERSIFIED
🧱 MATERIALS
💸 FINANCIALS
Imugene Ltd. is a biopharmaceutical company, which engages in the research, development, and commercialisation of health technologies against cancer. The company is headquartered in Sydney, New South Wales. The company is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to harness and promote the body’s immune system against cancerous tumors. Its product pipeline includes an off-the-shelf (allogeneic) cell therapy CAR T drug Azer-Cel (azercabtagene zapreleucel) which targets CD19 to attack blood cancer. Its pipeline includes an Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard of care drugs and immunotherapies. Its lead candidate is a chimeric vaccinia (pox) virus known as CF33, which is a combination of genomic sequences from multiple vaccinia virus strains to generate a new, safer and more potent virus. Its Chimeric antigen receptor (CAR)-engineered T cells (CAR T) are T cells redirected against tumors through engineered expression of CARs.
🙌 Performance (5Yr p.a)
-5.00%
📊 Share price
$0.04 AUD
🧬 BIOTECHNOLOGY
NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.
🙌 Performance (5Yr p.a)
25.73%
📊 Share price
$47.45 AUD
🤖 TECHNOLOGY
📈 HIGH PRICE GROWTH
A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 6041.2m in AUM and 200 holdings. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.
🙌 Performance (5Yr p.a)
4.86%
📊 Share price
$140.68 AUD
🇦🇺 AUSTRALIA
💸 FINANCIALS
⛳️ DIVERSIFIED
Want more shares? Try these...
Paradigm Biopharmaceuticals Ltd. is a biopharmaceutical company engaged in researching and developing therapeutic products for human use. The company is headquartered in Melbourne, Victoria. The company went IPO on 2015-08-19. The firm is engaged in discovering, developing, and delivering pharmaceutical therapies. The company is focused on the development of injectable pentosan polysulfate sodium (iPPS/PPS) for the treatment of osteoarthritis (OA) and mucopolysaccharidosis (MPS). Pentosan polysulfate sodium is a semi-synthetic drug manufactured from the wood chips of European beech trees. Extracted glucurono-xylans are sulfated to produce a negatively charged product that mimics glycosaminoglycans (GAGs). The company develops PPS under the brand name Zilosul. PPS also inhibits the synthesis of the metalloproteinase, MMP-3 (Troeberg) involved in degrading cartilage. PPS also include treatment of joint function, mobility, and pain in patients with MPS; treating alphavirus-induced arthralgia (such as Ross River virus and Chikungunya); chronic heart failure (HF) and acute respiratory distress syndrome (ARDS).
🙌 Performance (5Yr p.a)
-18.21%
📊 Share price
$0.33 AUD
🧬 BIOTECHNOLOGY
Pacific Current Group Ltd. engages in the business of investing in asset managers, private advisory, placement, and investment related firms. The company is headquartered in Sydney, New South Wales and currently employs 20 full-time employees. The firm is engaged in investing in asset managers, private advisory, placement and investment-related firms on a global basis. The firm operates a portfolio of 15 specialist boutiques in Australia, India, Luxembourg, the United States, and the United Kingdom. The Company’s portfolio represents an array of strategies, diversified across investment strategy, geography, revenue model, and client type. Its portfolio of companies includes Aether Investment Partners, LLC, Astarte Capital Partners, LLP, Carlisle Management Company, S.C.A., Cordillera Investment Partners, LP, Victory Park Capital Advisors, LLC and others. Aether Investment Partners, LLC is focused on private investments in natural resources, infrastructure and opportunistic real assets. Astarte Capital Partners, LLP is focused on infrastructure, natural resources, transportation, and real estate.
🙌 Performance (5Yr p.a)
12.32%
📊 Share price
$10.73 AUD
📈 HIGH PRICE GROWTH
💰 HIGH DIVIDEND
💸 FINANCIALS
Platinum Asia Investments Ltd is a AU-based company operating in industry. The company is headquartered in Sydney, New South Wales. The company went IPO on 2015-09-21. Platinum Asia Investments Limited is an Australia-based investment company. The firm's investment objective is to provide capital growth over the long term through investing primarily in undervalued listed securities of companies in the Asian region (ex-Japan) across sectors. The company offers investors an easy and convenient means of accessing an actively managed, diversified portfolio of Asian (ex-Japan) companies across industry sectors, providing exposure to undervalued businesses that are benefiting from Asia’s dynamic growth and transformation. The company aims to achieve net returns over a five-year plus investment horizon that are in excess of the benchmark (MSCI All Country Asia ex Japan Net Index (A$)) returns. The company invests in sectors that include consumer discretionary, industrials, information technology, real estate, financials, materials, consumer staples, communication services, health care, energy and others. The Company’s investment manager is Platinum Investment Management Limited.
🙌 Performance (5Yr p.a)
-1.36%
📊 Share price
$0.98 AUD
💰 HIGH DIVIDEND